Shares of Consun Pharmaceutical Group Limited (HKG:1681) surged as much as 9.09% in intraday trading on August 21, 2024, following the company's release of its interim financial results for the first half of the year.
According to a filing with the Hong Kong stock exchange, Consun Pharmaceutical reported a 15% increase in profit attributable to owners, reaching 399.8 million yuan for the six months ended June 30, 2024. The company's revenue for the same period grew by 13% year-over-year to 1.27 billion yuan.
The strong financial performance prompted the pharmaceutical firm to propose an interim dividend of HK$0.003 per share. Investors reacted positively to the news, driving Consun Pharmaceutical's share price up by 7% in recent trading, as mentioned in the company's filing.
Comments